Unknown OBSERVATIONAL NCT01628757

Model Development and Prospective Validation to Predict the Response to Neoadjuvant Chemotherapy in Cervical Cancer

Sponsor: Ding Ma

Updated 12 times since 2017 Last updated: May 13, 2016 Primary completion: Dec 31, 2018 Completion: Dec 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Cervical Cancer and is currently ongoing. Ding Ma leads this study, which shows 12 recorded versions since 2026 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

12 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2024 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Dec 2021 — Jan 2024 [monthly]

Recruiting
Oct 2021 — Dec 2021 [monthly]

Recruiting

▶ Show 7 earlier versions

Jan 2021 — Oct 2021 [monthly]

Recruiting
Nov 2020 — Jan 2021 [monthly]

Recruiting
Jun 2018 — Nov 2020 [monthly]

Recruiting
May 2018 — Jun 2018 [monthly]

Recruiting
Apr 2018 — May 2018 [monthly]

Recruiting

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Recruiting NA
Jan 2017 — Aug 2017 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ding Ma
Hubei University for nationalities
Hubei Women and Children's Hospital
Shandong University
Sun Yat-sen University
Wuhan Central Hospital
Wuhan General Hospital of Guangzhou Military Command
Wuhan University
Xiangfan Central Hospital
Zhejiang University

Data source: Huazhong University of Science and Technology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Wuhan, China